Thus, prophylactic and therapeutic treatment with bindarite, a blocker of MCP-1 synthesis, significantly protected mice from sepsis and endotoxemia, as evidenced by attenuation of neutrophil activity in the lungs and liver [52]. This evidence concerns the gene CCL2 and serum lipopolysaccharide activity.